Synthesis of highly substituted enantiopure piperazines and ketopiperazines from vicinal N-sulfinyl diamines

Journal of Organic Chemistry

Volumn 71, Issue 4, 2006, Pages 1442-1448

  Viso, Alma ^a   Fernández De La Pradilla, Roberto ^a   Flores, Aida ^a   García, Ana ^a   Tortosa, Mariola ^a   López Rodríguez, María L ^b  

^a INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROACETYL CHLORIDE; ENANTIOPURE PIPERAZINES; KETOPIPERAZINES; N-SULFINYL DIAMINES;

ACYLATION; ALCOHOLS; AMINES; KETONES; SYNTHESIS (CHEMICAL);

NITROGEN COMPOUNDS;

1 BENZYL 6 (TERT BUTYLDIMETHYLSILYLOXYMETHYL) 5 (ISOPROPYL) 5,6 DIHYDRO 1H PYRAZIN 2 ONE; BORANE DERIVATIVE; CERIUM; DIAMINE DERIVATIVE; IMINE; METHOXIDE SODIUM; N SULFINYL N BENZYLDIAMINOALCOHOL; N SULFINYLKETOPIPERAZINE DERIVATIVE; OXALIC ACID DERIVATIVE; OXALIC ACID ESTER; OXIDE; PIPERAZINE DERIVATIVE; SODIUM HYDROXIDE; UNCLASSIFIED DRUG;

ACYLATION; ALLYLATION; ARTICLE; CYCLIZATION; DRUG STRUCTURE; ENANTIOMER; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

ACYLATION; CYCLIZATION; DIAMINES; INDICATORS AND REAGENTS; KETONES; PIPERAZINES; STEREOISOMERISM; SULFUR COMPOUNDS;

EID: 33644535452     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo052077h     Document Type: Article

References (65)

1. (a) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893-930.
2. Some recent references: (b) Ryckebusch, A.; Debreu-Fontaine, M.-A.; Mouray, E.; Grellier, P.; Sergheraert, C.; Melnyk, P. Bioorg. Med. Chem. Lett. 2005, 15, 297-302.
3. (c) Ding, K.; Chen, J.; Ji, M.; Wu, X.; Varady, J.; Yang, C.-Y.; Lu, Y.; Deschamps, J. R.; Levant, B.; Wang, S. J. Med. Chem. 2005, 48, 3171-3181.
4. (d) Shao, B.; Huang, J.; Sun, Q.; Valenzano, K. J.; Schmid, L.: Nolan, S. Bioorg. Med. Chem. Lett. 2005, 15, 719-723.
5. (e) Wiesner, J.; Kettler, K.; Sakowski, J.; Ortmann, R.; Katzin, A. M.; Kimura, E. A.; Silber, K.; Klebe, G.; Jomaa, H.; Schlitzer, M. Angew. Chem., Int. Ed. 2004, 43, 251-254.
6. Dorsey, B. D.; Levin, R. B.; McDaniel, S. L.; Vacca, J. P.; Guare, J. P.; Darke, P. L.; Zugay, J. A.; Emini, E. A.; Schleif, W. A.; Quintero, J. C.; Lin, J. H.; Chen, I.-W.; Holloway, M. K.; Fitzgerald, P. M. D.; Axel, M. G.; Ostovic, D.; Anderson, P. S.; Huff, J. R. J. Med. Chem. 1994, 37, 3443-3451.
7. Capdeville, R.; Buchdunger, E.; Zimmermann, J.; Matter, A. Nat. Rev. 2002, 1, 493-502.
8. (a) López-Rodríguez, M. L.; Ayala, D.; Benhamú, B.; Morcillo, M. J.; Viso, A. Curr. Med. Chem. 2002, 9, 1867-1894.
9. (b) Olivier, B.; Soudijn, W.; van Wijngaarden, I. Prog. Drug Res. 1999, 52, 103-165.
10. Leading references on ET-743 and related compounds: (a) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Keifer, P. A.; Wilson, G. R.; Perun, T. J., Jr.; Sakai, R.; Thompson, A. G.; Stroh, J. G.; Shield, L. S.; Seigler, D. S.; Li, L. H.; Martin, D. G.; Grimmelikhuijzen, C. J. P.; Gäde, G. J. Nat. Prod. 1990, 53, 771-792.
11. (b) Scott, J. D.; Williams, R. M. Chem. Rev. 2002, 102, 1669-1730.
12. (c) Gonzalez, J. F.; Salazar, L.; de la Cuesta, E.; Avendaño, C. Tetrahedron 2005, 61, 7447-7455.
13. Wardrop, D. J.; Basak, A. Org. Lett. 2001, 3, 1053-1056.
14. (a) Miyake, F. Y.; Yakushijin, K.; Horne, D. A. Org. Lett. 2000, 2, 3185-3187.
15. For other piperazines with significant biological actitvity, see: (b) Bedürftig, S.; Weigl, M.; Wünsch, B. Tetrahedron: Asymmetry 2001, 12, 1293-1302 and references therein.
16. (c) Yang, C.; Xu, G.; Li, J.; Wu, X.; Liu, B.; Yan, X.; Wang, M.; Xie, Y. Bioorg. Med. Chem. Lett. 2005, 15, 1505-1507.
17. Dinsmore, C. J.; Bogusky, M. J.; Culberson, J. C.; Bergman, J. M.; Homnick, C. F.; Zartman, C. B.; Mosser, S. D.; Schaber, M. D.; Robinson, R. G.; Koblan, K. S.; Huber, H. E.; Graham, S. L.; Hartman, G. D.; Huff, J. R.; Williams, T. M. J. Am. Chem. Soc. 2001, 123, 2107-2108.
18. (a) Herrero, S.; García-López, M. T.; LaTorre, M.; Cenarruzabeitia, E.; Del Rio, J.; Herranz, R. J. Org. Chem. 2002, 67, 3866-3873.
19. (b) Rübsam, F.; Mazitschek, R.; Giannis, A. Tetrahedron 2000, 56, 8481-8487.
20. (c) Nefzi, A.; Giulianotti, M. A.; Houghten, R. A. Tetrahedron 2000, 56, 3319-3326.
21. For other biologically active ketopiperazines, see: (a) Govek, S. P.; Overman, L. E. J. Am. Chem. Soc. 2001, 123, 9468-9469.
22. (b) Jacquot, D. E. N.; Zollinger, M.; Lindel, T. Angew. Chem., Int. Ed. 2005, 44, 2295-2298.
23. (c) Williams, R. M.; Cao, J.; Tsujishima, H. Angew. Chem., Int. Ed. 2000, 39, 2540-2544.
24. (a) Eriksson, J.; Arvidsson, P. I.; Davidsson, Ö. Chem. Eur. J. 1999, 5, 2356-2361.
25. (b) Iyer, M. S.; Gigstad, K. M.; Namdev, N. D.; Lipton, M. J. Am. Chem. Soc. 1996, 118, 4910-4911.
26. (c) Itsuno, S.; Matsumoto, T.; Sato, D.; Inoue, T. J. Org. Chem. 2000, 65, 5879-5881.
27. For a review, see: (a) Dinsmore, C. J.; Beshore, D. C. Tetrahedron 2002, 58, 3297-3312.
28. For recent references, see: (b) Powell, N. A.; Ciske, F. L.; Clay, E. C.; Cody, W. L.; Downing, D. M.; Blazecka, P. G.; Holsworth, D. D.; Edmunds, J. J. Org. Lett. 2004, 6, 4069-4072.
29. (c) Bedürftig, S.; Wünsch, B. Bioorg. Med. Chem. 2004, 12, 3299-3311.
30. (d) Williams, A. J.; Chakthong, S.; Gray, D.; Lawrence, R. M.; Gallagher, T. Org. Lett. 2003, 5, 811-814.
31. (e) Davies, S. G.; Rodríguez-Solla, H.; Tamayo, J. A.; Cowley, A. R.; Concellón, C.; Garner, A. C.; Parkes, A. L.; Smith, A. D. Org. Biomol. Chem. 2005, 3, 1435-1447.
32. (f) Berkhei, M.; van der Sluis, J. L.; Sewing, C.; den Boer, D. J.; Terpstra, J. W.; Hiemstra, H.; Bakker, W. I. I.; van den Hoogenband, A.; van Maarseveen, J. H. Tetrahedron Lett. 2005, 46, 2369-2371.
33. (g) Franceschini, N.; Sonnet, P.; Guillaume, D. Org. Biomol. Chem. 2005, 3, 787-793.
34. (h) Sollis, S. L. J. Org. Chem. 2005, 70, 4735-4740.
35. (i) Chai, C. L. L.; Elix, J. A.; Huleatt, P. B. Tetrahedron 2005, 61, 8722-8739.
36. (j) Revesz, L.; Blum, E.; Wicki, R. Tetrahedron Lett. 2005, 46, 5577-5580.
37. For reviews on vicinal diamines, see: (a) Viso, A.; Fernández de la Pradilla, R.; García, A.; Flores, A. Chem. Rev. 2005, 105, 3167-3196.
38. (b) Lucet, D.; Le Gall, T.; Mioskowski, C. Angew. Chem., Int. Ed. 1998, 37, 2580-2627.
39. (a) López-Rodríguez, M. L.; Benhamú, B.; Ayala, D.; Rominguera, J. L.; Murcia, M.; Ramos, J. A.; Viso, A. Tetrahedron 2000, 56, 3245-3253.
40. (b) López-Rodríguez, M. L.; Ayala, D.; Viso, A.; Benhamú, B.; Fernández de la Pradilla, R.; Zarza, F.; Ramos, J. A. Bioorg. Med. Chem. 2004, 12, 1551-1557.
41. (c) López-Rodríguez, M. L.; Morcillo, M. J.; Fernández, E.; Benhamú, B.; Tejada, I.; Ayala, D.; Viso, A.; Campillo, M.; Pardo, L.; Delgado, M.; Manzanares, J.; Fuentes, J. A. J. Med. Chem. 2005, 48, 2548-2558.
42. (a) Viso, A.; Fernández de la Pradilla, R.; García, A.; Guerrero-Strachan, C.; Alonso, M.; Flores, A.; Martínez-Ripoll, M.; Fonseca, I.; André, I.; Rodríguez, A. Chem. Eur. J. 2003, 9, 2867-2876.
43. (b) Viso, A.; Fernández de la Pradilla, R.; García, A.; Alonso, M.; Guerrero-Strachan, C.; Fonseca, I. Synlett 1999, 755-758.
44. (c) Viso, A.; Fernández de la Pradilla, R.; López- Rodríguez, M. L.; García, A.; Flores, A.; Alonso, M. J. Org. Chem. 2004, 69, 1542-1547.
45. For a review on sulfinimines, see: (a) Zhou, P.; Chen, B. C.; Davis, F. A. Tetrahedron 2004, 60, 8003-8030.
46. For some recent references, see: (b) Fernández, I.; Valdivia, V.; Gori, B.; Alcudia, F.; Álvarez, E.; Khiar, N. Org. Lett. 2005, 7, 1307-1310.
47. (c) Scott, M. E.; Lautens, M. Org. Lett. 2005, 7, 3045-3047.
48. (d) Davis, F. A.; Nolt, M. B.; Wu, Y.; Prasad, K. R.; Li, D.; Yang, B.; Bowen, K.; Lee, S. H.; Eardley, J. H. J. Org. Chem. 2005, 70, 2184-2190.
49. Falorni, M.; Lardicci, L.; Giacomelli, G.; Marchetti, M. Tetrahedron Lett. 1989, 30, 3551-3554.
50. Dinsmore, C. J.; Bergman, J. M.; Bogusky, M. J.; Culberson, J. C.; Hamilton, K. A.; Graham, S. L. Org. Lett. 2001, 3, 865-868.
51. We have speculated about secondary processes caused by the acidity of the amide (CONH) and the carbon α-to the ester; however, the precise origin of the failure of these cyclizations remains unclear.
52. (a) Bull, S. D.; Davies, S. G.; Garner, A. C.; Savory, E. D.; Snow, E. J.; Smith, A. D. Tetrahedron: Asymmetry 2004, 15, 3989-4001.
53. (b) Brook, D. J. R.; Noll, B. C.; Koch, T. H. J. Chem. Soc., Perkin Trans. 1 1988, 289-292.
54. (c) Singh, S. B.; Tomassini, J. E. J. Org. Chem. 2001, 66, 5504-5516.
55. For reviews, see: (a) Enders, D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895-1946.
56. (b) Alvaro, G.; Savoia, D. Synlett 2002, 651-673.
57. Hou, X. L.; Zheng, X. L.; Dai, L. X. Tetrahedron Lett. 1998, 39, 6949-6952.
58. For leading references, see: (a) Kulesza, A.; Mieczkowski, A.; Jurczak, J. Tetrahedron: Asymmetry 2002, 13, 2061-2069.
59. (b) Fang, X.; Johannsen, M.; Yao, S.; Gathergood, N.; Hazell, R. G.; Jørgensen, K. A. J. Org. Chem. 1999, 64, 4844-4849.
60. (c) Ukai, Y.; Kume, K.; Watai, T.; Fujisawa, T. Chem. Lett. 1991, 173-176.
61. (d) Kulesza, A.; Jurczak, J. Synthesis 2003, 2110-2114.
62. (e) Basile, T.; Bocoum, A.; Savoia, D.; Umani-Ronchi, A. J. Org. Chem. 1994, 59, 7766-7773.
63. (f) Martelli, G.; Morri, S.; Savoia, D. Synlett 2002, 158-160.
64. 2O and CHiPr protons were observed (see Supporting Information).
65. 2OP, and Bn) for N-sulfinyl ketopiperazines 8 and imino ketopiperazines 9 that was confirmed by DNOE experiments (see Experimental Procedures). For a related example, see: (a) Knapp, S.; Morriello, G. J.; Doss, G. A. Tetrahedron Lett. 2003, 44, 2645-2647.